Skip to content

Clinical study of Shengmai decoction in enhanced recovery after surgery (ERAS)

Clinical study of Shengmai decoction in enhanced recovery after surgery (ERAS)

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086481
Enrollment
Unknown
Registered
2024-07-02
Start date
2023-03-05
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

Experimental group:Using Shengmai decoction(The sub-project is the same as the major project)
Control group:Drinking water(The sub-project is the same as the major project)

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. 18-70 years old; 2. After neoadjuvant chemotherapy, breast cancer surgery, esophageal cancer surgery, ovarian cancer surgery, gastric cancer surgery, colon cancer surgery, lung cancer surgery; 3. Elective surgery; 4. Informed consent was obtained from patients or their family member Subtopic 1: Clinical study on perioperative rapid recovery of patients undergoing surgery after neoadjuvant chemotherapy for breast cancer using Shengmai decoction: 1.18 ~ 70 years old; 2. After neoadjuvant chemotherapy, breast cancer surgery is planned; 3. Elective surgery; 4. Patients or family members give informed consent and sign informed consent. Subtopic 2: Clinical study on the application of shengmai decoction to promote perioperative rapid recovery in patients undergoing surgery after neoadjuvant chemotherapy for esophageal cancer: 1.18 ~ 70 years old; 2. Esophageal cancer surgery was planned after neoadjuvant chemotherapy; 3. Elective surgery; 4. Patients or family members give informed consent and sign informed consent. Subtopic 3: Clinical study on perioperative rapid recovery of patients with ovarian cancer after neoadjuvant chemotherapy using Shengmai decoction: 1.18 ~ 70 years old; 2. Neoadjuvant chemotherapy was followed by ovarian cancer surgery; 3. Elective surgery; 4. Patients or family members give informed consent and sign informed consent. Subtopic 4: Clinical study on the application of shengmai decoction to promote perioperative rapid recovery in patients undergoing surgery after neoadjuvant chemotherapy for gastric cancer: 1.18-70 years old; 2. Neoadjuvant chemotherapy was followed by gastric cancer surgery; 3. Elective surgery; 4. Patients or family members give informed consent and sign informed consent. Sub-topic 5: Clinical study on the application of shengmai decoction to promote perioperative rapid recovery in patients with colorectal cancer after neoadjuvant chemotherapy: 1.18 ~ 70 years old; 2. After neoadjuvant chemotherapy, bowel cancer operation was proposed; 3. Elective surgery; 4. Patients or family members give informed consent and sign informed consent. Subtopic 6: Clinical study on the application of pulse-making drink to promote perioperative rapid recovery in patients undergoing surgery after neoadjuvant chemotherapy for lung cancer: 1.18 ~ 70 years old; 2. After neoadjuvant chemotherapy, lung cancer surgery is planned; 3. Elective surger

Exclusion criteria

Exclusion criteria: 1. Allergic to the composition of drugs in Shengmai decoction; 2. Patients with unresectable tumors or distant metastases found during the operation; 3. Patients who had performed TCM treatment one month before hospitalization; 4. Patients with severe failure of heart, liver, kidney and other organs; 5. Pregnant and lactating women; 6. Suffering from mental illness, unable to communicate, unable to provide informed consent; 7. Patients or family members are unable to cooperate with or refuse to complete the quality of life score of cancer patients. The exclusion criteria for sub-topics are the same as above.

Design outcomes

Primary

MeasureTime frame
Quality of life score, QOL,(The sub-project is the same as the major project);

Secondary

MeasureTime frame
First time out of bed(The sub-project is the same as the major project);Time of first exhaust(The sub-project is the same as the major project);Time of first feeding(The sub-project is the same as the major project);Time to first bowel movement((The sub-project is the same as the major project));Drain indwelling time(The sub-project is the same as the major project);Hospital stays((The sub-project is the same as the major project));myocardial enzyme(The sub-project is the same as the major project);

Countries

China

Contacts

Public ContactDing Chao

Cancer Hospital, Chinese Academy of Medical Sciences

13501313926@163.com+86 189 1191 3926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026